Students from the Kirk Kerkorian School of Medicine at UNLV recently received their Doctor of Medicine degrees when they walked across the stage at the Thomas & Mack Center. We caught up with some of them excited for the next step.

Lighthouse Pharmaceuticals, a clinical-stage pharmaceutical company developing therapeutics to alter the course of dementia and other degenerative diseases, announced completion of a Pre-investigational New Drug meeting with the Food and Drug Administration related to the planned Phase 2b clinical study of LHP588 and the formation of its Clinical Advisory Board (CAB). The CAB includes six members with diverse backgrounds and expertise in dementia, Alzheimer’s disease, inflammation, neurodegenerative disorders, and drug development.

UNLV Vice President of Economic Development Bo Bernhard recalled how two years ago, the university’s new president wanted to see cutting-edge high-tech companies populate the school’s recently opened Harry Reid Research & Technology Park.

A new drug shows promising results in trials, but questions remain about whether benefits outweigh side effects.

Austin Wang, an assistant professor of political science at the University of Nevada, Las Vegas, believes that in order to stabilize the US-China relationship and get it back on track, Washington is not without demands on Beijing.

Conference comes ahead of anniversary of legal sports betting

The claim: Radar technology wouldn’t work if the Earth was a globe. Our rating: False.

An updated alternative to a proposed transit improvement project for Tropicana Avenue near UNLV saved Clark County millions of dollars.